Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients.

Park, Song Y; Church, Candice; Alexander, Nora A; Shinohara, Michi M; Paulson, Kelly G; Lewis, Karl D; Lee, Nancy S; Nghiem, Paul

Park, Song Y; Church, Candice; Alexander, Nora A; Shinohara, Michi M; Paulson, Kelly G; Lewis, Karl D; Lee, Nancy S; Nghiem, Paul.

Afiliação

Park SY; University of Washington, Seattle, Washington.
Church C; University of Washington, Seattle, Washington.
Alexander NA; University of Washington, Seattle, Washington.
Shinohara MM; University of Washington, Seattle, Washington.
Paulson KG; Swedish Cancer Institute, Seattle/Edmonds, Washington.
Lewis KD; University of Colorado Cancer Center, Aurora, Colorado.
Lee NS; Kaiser Permanente, Hematology and Oncology, San Diego, California.
Nghiem P; University of Washington, Seattle, Washington.

JAAD Case Rep ; 8: 28-33, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33490342

Palavras-chave

AIDS; CR, complete response; HIV; ICI, immune checkpoint inhibitors; IHC, immunohistochemistry; MCC; MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus; Merkel cell carcinoma; PD-1, anti-programmed cell death-1; PD-L1, anti-programmed death ligand-1; PET, positron emission tomography; RT, radiation treatment; aMCC, advanced Merkel cell carcinoma; anti-PD-(L)1 agent; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Ano de publicação: 2021 Tipo de documento: Article